Antipsychotic Pharmacology Flashcards
Antipsychotics are separated into first generation and second generation. What is the major difference between the generations?
Reduction in movement disorder AEs from first to second gen
MOA of first generation antipsychotics (aka “conventional” or “typical”)
Primarily block dopamine type 2 (D2) postsynaptic receptors
[D2»_space; 5HT2]
Also block one or more other receptors with varying potencies — primarily inducing AEs
First gen antipsychotics may increase risk of _____ prolongation and ______ activity
QTc; seizure
Many AEs of first gen antipsychotics are based on their inhibition of various other receptors, including muscarinic, histamine, alpha-adrenergic (primarily alpha 1), and D2 receptors in nigrostriatal and tuberoinfundibular pathways.
What AEs are associated with first gen antipsychotic-induced inhibition at muscarinic receptors?
Dry mouth Constipation Urinary retention Blurry vision Sedation
Many AEs of first gen antipsychotics are based on their inhibition of various other receptors, including muscarinic, histamine, alpha-adrenergic (primarily alpha 1), and D2 receptors in nigrostriatal and tuberoinfundibular pathways.
What AEs are associated with first gen antipsychotic-induced inhibition at histamine receptors (primarily H1)?
Sedation
Many AEs of first gen antipsychotics are based on their inhibition of various other receptors, including muscarinic, histamine, alpha-adrenergic (primarily alpha 1), and D2 receptors in nigrostriatal and tuberoinfundibular pathways.
What AEs are associated with first gen antipsychotic-induced inhibition at alpha-adrenergic receptors?
Orthostatic hypotension
Dizziness/syncope
Many AEs of first gen antipsychotics are based on their inhibition of various other receptors, including muscarinic, histamine, alpha-adrenergic (primarily alpha 1), and D2 receptors in nigrostriatal and tuberoinfundibular pathways.
What AEs are associated with first gen antipsychotic-induced inhibition at D2 receptors in nigrostriatal pathway?
Extrapyramidal symptoms (EPS) — acute akathisia/dystonia/parkinsonism-like
Tardive dyskinesia
Many AEs of first gen antipsychotics are based on their inhibition of various other receptors, including muscarinic, histamine, alpha-adrenergic (primarily alpha 1), and D2 receptors in nigrostriatal and tuberoinfundibular pathways.
What AEs are associated with first gen antipsychotic-induced inhibition at D2 receptors in tuberoinfundibular pathway?
Hyperprolactinemia —> amenorrhea, galactorrhea, gynecomastia, decreased libido
Treatment options for EPS adverse effects of first gen antipsychotics (akasthesia, dystonia, parkinsonism-like syndrome)
Anticholinergic agents — benzotropine and trihexyphenidyl
Antihistamines — diphenhydramine
[these are both used for acute tx and maintenance]
Treatment for tardive dyskinesia induced by first gen antipsychotic’s activity at nigrostriatal pathway
Valbenazine
Deutetrabenazine
[Selective vesicular monoamine transporter 2 (VMAT2) inhibitors]
The first gen antipsychotics are separated into low potency and high potency agents. What is the difference between the two categorizations?
Low potency cause more sedation, hypotension, and reduction of seizure threshold
High potency cause more movement (EPS) and endocrine (prolactin) effects
List the 5 first gen antipsychotics based on their categorization as either low potency or high potency agents
Low potency agents:
- Chlorpromazine
- Thioridazine
High potency agents:
- Fluphenazine
- Haloperidol
- Thiothixene
Second generation antipsychotics are also referred to as “Novel” or “atypical” antipsychotics. What 6 drugs are in this category?
Aripiprazole Clozapine Olanzapine Quetiapine Risperidone Ziprasidone
What second generation antipsychotic is used in the treatment for recurrent suicidal behavior?
Clozapine
MOA of second generation antipsychotics
Block both D2 postsynaptic receptors and 5HT-2A
[5HT-2A»_space; D2]
Note: some block one or more other DA receptors (1, 3-5) and also have greater propensity to be an agonist/antagonist on one or more other 5HT receptors (other than 5HT2A blockade)
_______________________
[5HT2A antagonism in PFC theorized to increase DA transmission in mesocortical pathway — May contribut to improved negative and cognitive symptoms and reduced EP adverse effects]